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SUMMARY
Sialic acids (Sias), 9-carbon-backbone sugars, are
among the most complex and versatile molecules
of life. As terminal residues of glycans on proteins
and lipids, Sias are key elements of glycotopes of
both cellular and microbial lectins and thus act as
important molecular tags in cell recognition and
signaling events. Their functions in such interac-
tions can be regulated by post-synthetic modi-
fications, the most common of which is differen-
tial Sia-O-acetylation (O-Ac-Sias). The biology of
O-Ac-Sias remains mostly unexplored, largely
because of limitations associated with their spe-
cific in situ detection. Here, we show that dual-
function hemagglutinin-esterase envelope proteins
of nidoviruses distinguish between a variety of
closely related O-Ac-Sias. By using soluble forms
of hemagglutinin-esterases as lectins and sia-
late-O-acetylesterases, we demonstrate differential
expression of distinct O-Ac-sialoglycan popula-
tions in an organ-, tissue- and cell-specific fashion.
Our findings indicate that programmed Sia-O-acet-
ylation/de-O-acetylation may be critical to key
aspects of cell development, homeostasis, and/or
function.
INTRODUCTION
Cells are covered by a dense thicket of glycans. Though
attached to proteins and lipids, these oligo- and polysaccharides
are more than decoration. With a structural complexity vastly
exceeding that of proteins and nucleic acids, they act as molec-
ular tags in cell recognition and signaling events. Mammalian gly-
cans form linear and branched chains of variable size and
composition yet commonly with sialic acids (Sias) as terminal,
surface-exposed residues. In consequence of this topology,
Sias are key elements of the glycotopes of many regulatory
cellular lectins (Crocker et al., 2007; Schauer, 2009). For the
same reason, they have become attachment factors of choice
for a range of pathogens including protozoa, fungi, bacteria,
and viruses.
Sias occur in a wide variety, their diversity resulting from differ-
ences in glycosidic linkage as well as from differential modifica-
tions (Deng et al., 2013). In most mammals, humans excluded,
the parental Sia N-acetylneuraminic acid (Neu5Ac) can be enzy-
matically converted to N-glycolylneuraminic acid (Neu5Gc)
(Chou et al., 1998; Irie et al., 1998). Another common modifica-
tion is Sia-O-acetylation substituting the hydroxyl groups at car-
bon atoms C4, C7, C8, and/or C9 (Kamerling and Gerwig, 2006;
Klein and Roussel, 1998) (Figure S1). In lock-and-key interac-
tions, the presence or absence of these O-acetyl moieties can
block or promote binding of cellular and microbial lectins, and
their controlled addition and removal through sialate-O-acety-
lesterases (SOAEs) and sialate-O-transferases (SOATs) may
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thus act as a molecular switch to control downstream processes
and events. This principle is illustrated by the regulation of
peripheral B cell tolerance. Repression of antigen receptor
signaling through Sia-dependent binding of Siglec 2/CD22 to
the B cell receptor is modulated by Sia-9-O-acetylation/de-O-
acetylation (Cariappa et al., 2009), and defects in SOAE expres-
sion may be associated with autoimmunity (Pillai, 2013; Surolia
et al., 2010). Defective (de-)O-acetylation of Sias has also been
implicated in cancer to correlate with metastatic potential,
escape from apoptosis and drug resistance (Bu¨ll et al., 2014;
Ghosh et al., 2007; Mukherjee et al., 2008; Parameswaran
et al., 2013).
There is limited understanding of how O-acetylation of Sias is
regulated, and the role of distinct O-acetylated (O-Ac) Sias in
health and disease remains largely unexplored. A major hurdle
for advancement of this field is a lack of convenient experimental
approaches that would allow detection of, and distinction
between, Sia variants in situ. Viruses that use Sias as receptor
determinants come with a treasure trove of lectins and sugar-
modifying enzymes (Neu et al., 2011). For example, the hemag-
glutinin-esterase proteins (HEs) of toro-, corona-, and ortho-
myxo-viruses are envelope glycoproteins thatmediate reversible
virion attachment to O-Ac-Sias through the concerted action
of distinct lectin and receptor-destroying (SOAE) domains (Fig-
ure S1A) (de Groot, 2006; Langereis et al., 2009; Langereis
et al., 2012; Zeng et al., 2008). Here, we investigated the
biochemical and structural properties of toro- and coronavirus
HEs with particular focus on their receptor specificity, and their
potential use as tools in explorative sialoglycobiology. We
demonstrate that the nidovirus ‘‘virolectins’’ have evolved to
bind differentO-Ac-Sia variants selectively and with such affinity
as to allow detection of distinct O-Ac-sialoglycan populations in
mammalian cells and tissues. We show that O-Ac-sialoglycans
are expressed differentially in a species-, organ-, tissue-, and
cell-type-specific fashion and that their expression is regulated
even at the level of the individual cell.
RESULTS AND DISCUSSION
Toroviruses and group A betacoronaviruses (order Nidovirales,
family Coronaviridae; collectively referred to as nidoviruses
throughout) are positive-strand RNA viruses of mammals. Their
HEs share a common evolutionary origin with the influenza C
hemagglutinin-esterase fusion protein (HEF) and were added
to the respective virus proteomes relatively recently (de Groot,
2006; Zeng et al., 2008). In the course of evolution, nidovirus
HEs with novel SOAE substrate and lectin ligand specificities
arose. In one lineage of rodent coronaviruses, HE ligand and
substrate specificity shifted toward 4-O-Ac-Sias. Most nidovirus
HEs, however, resemble influenzaC virus HEF in that they bind to
9-O-Ac-Sias in a 9-O-acetyl-dependent fashion and function as
sialate-9-O-acetylesterases (de Groot, 2006). Yet, even among
this latter group of HEs, subtle but salient differences in SOAE
substrate preference are apparent. For instance, porcine torovi-
rus (PToV) HEs preferentially cleave 9-mono-O-Ac-Sias, while
those of bovine toroviruses (BToVs) display a preference for
7,9-di-O-acetylated substrates (Langereis et al., 2009; Smits
et al., 2005). Also, the HEs of bovine coronavirus (BCoV) and
influenza C virus, while more promiscuous in SOAE substrate
usage, do show a predilection for 7,9-di- or 9-mono-O-acety-
lated substrates, respectively (Figure S2A). All HEs readily cleave
O-acetyl groups both from 5-N-Gc- and 5-N-Ac-Sias, with some
HEs displaying a modest preference for the latter type (Fig-
ure S2B; for a summary of HE SOAE substrate specificities,
see Figure S2C).
To investigate whether SOAE substrate preference for 7,9-di-
or 9-mono-O-Ac-Sias reflects lectin ligand fine specificity, we
expressed a comprehensive set of nidovirus HEs as Fc fusion
proteins (Table S1) with the esterase inactivated through an
active site Ser-to-Ala substitution (HEs with inactive SOAE are
referred to as HE0 throughout; enzymatically active HEs are
referred to as HE+).
Nidovirus HEs: Virolectins of Different Receptor
Specificity
HE0-Fc virolectins were tested for Sia binding and ligand speci-
ficity by hemagglutination assay with rat red blood cells (RBCs)
and by solid-phase lectin binding assay (sp-LBA) with bovine
submaxillary mucin (BSM), a natural O-glycosylated sialoglyco-
conjugate exceptionally rich in (a2-6)-linked O-Ac-Sias (for an
extensive analysis of BSM Sia content, pivotal to this study,
see the Supplemental Experimental Procedures, Figures S1C
and S1D, and Tables S2 and S3).
Hemagglutination was observed for all nidovirus HEs. Pre-
treating RBCs with sialidase prevented hemagglutination, indi-
cating that in each case, agglutination was Sia-dependent
(data not shown). Selective depletion of 9-mono-O-Ac-Sias
from the cell surface with PToV HE+ prevented hemagglutination
by HE0-Fc of PToV strains Markelo and P4 but left that by BCoV,
equine coronavirus (ECoV), and BToV virolectins largely unaf-
fected. Conversely, depletion of 7,9-di-O-Ac-Sias with BToV-
Breda HE+ prevented hemagglutination by BCoV, ECoV, and
BToV HEs but did not reduce agglutination by PToV HE. De-O-
acetylation with BCoV HE+, which accepts both 9-mono- and
7,9-di-O-acetylated substrates (Figure S2), abrogated hemag-
glutination by all virolectins (Figure 1A).
In solid-phase assays, all HEs, except for 4-O-Ac-Sia-specific
MHV-S HE0 (Langereis et al., 2012), bound to BSM in a 9-O-Ac-
Sia-dependent fashion (data not shown), albeit with markedly
varied affinities (Figure 1B). Those of ECoV-NC99, BCoV-Mebus
and -LUN, and PToV-P4 bound exceptionally well and were
therefore studied further.
In accordance with the hemagglutination analyses, binding of
ECoV-NC99, BCoV-Mebus, and BCoV-LUN HE0 was lost upon
SOAE predigestion of BSM with either BCoV or BToV HE+ but
relatively resistant to de-O-acetylation of Sias by PToV HE+.
Conversely, binding of PToV-P4 HE0 was highly sensitive to pre-
treatment of BSM with PToV HE+, less sensitive to BCoV HE+,
and even far less so to BToV HE+ (Figure 1C).
Apparently, the differences between the ECoV and BCoV HEs
on the one hand and PToV-P4 HE on the other arise from a pref-
erence or intolerance for di-O-acetylation at the Sia glycerol side
chain. As a direct test, we performed sp-LBA with BSM, chemo-
enzymatically converted to carry 9-mono-O-Ac-Sias exclusively
(Figure 1D). To this end, BSM was first digested with excess
BCoV HE+ to selectively remove all Sia-9-O-acetyl moieties
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Figure 1. Nidovirus Virolectins Distinguish
between 9-Mono-O- and 7,9-Di-O-Ac-Sias
(A) Hemagglutination assay with 2-fold serial di-
lutions of esterase-inactive HE0-Fc virolectins. Prior
to hemagglutination assay, RBCs were mock
treated, depleted for O-Ac-Sias with BCoV-Mebus
HE+-Fc, or selectively depleted for 7,9-di-O- or
9-mono-O-Ac-Sias with BToV-Breda or PToV-
Markelo HE+-Fc, respectively. Wells positive for
hemagglutination are encircled.
(B) Nidovirus HEs bind to O-Ac-Sias in BSM with
widely different affinities. Lectins (in 2-fold serial
dilutions, starting at 0.1 mg/ml) were compared by
sp-LBA for relative binding to BSM (OD450 value for
0.1 mg/ml PToV-P4 HE0-Fc set at 100%). Data pre-
sented as mean ± SD. Descending concentrations
of HE0-Fc virolectins, plotted on the x axis, are
schematically indicated by black descending tri-
angles.
(C) sp-LBA with BSM, after on-the-plate depletion
for distinct O-Ac-Sia populations with BCoV-Me-
bus, BToV-Breda, or PToV-P4 HE+-Fc. Receptor
destruction was assessed by sp-LBA with BCoV-
Mebus or PToV-P4 HE0-Fc at fixed concentrations
(5 ng/ml and 1 ng/ml, respectively).
(D) Differences in receptor preference between
BCoV-LUN and PToV-P4 HE revealed by chemo-
enzymatical modification of BSMO-Ac-Sia content.
Top: experimental outline. Middle: gas-liquid chro-
matography-electron ionization mass spectrometry
(GLC-EIMS) profiles of corresponding BSM
preparations (peaks are numbered as in Table S2:
peak 3; b-Neu5,7Ac2, peak 4; b-Neu5,9Ac2, peak 5;
b-Neu5,7,9Ac3, peak 9; b-Neu5Gc7Ac, peak 11;
b-Neu5Gc7,9Ac2, peak 12; b-Neu5Gc9Ac). Bottom:
sp-LBA as in (B).
See also Figure S1 and Table S1.
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while leaving 7-O-acetyl groups attached. In result, binding of
both BCoV-LUN and PToV-P4 HE0 was lost (Figure 1D), formally
demonstrating that Sia-9-O-acetylation is a strict requirement
and that 7-mono-O-Ac-Sias do not serve as ligands. Upon pH/
temperature-induced C7-to-C9 migration of O-acetyl moieties
(Kamerling et al., 1987) as to produce 9-mono-O-Ac-Sias, bind-
ing of PToV-P4 HE0 was restored to levels even beyond those in
native BSM (note that in native BSM, the amount of 7-O-Ac- and
7,9-di-O-Ac-Sias combined is almost twice that of 9-mono-O-
Ac-Sias; Tables S2 and S3). Binding of BCoV-LUN HE0, how-
ever, was restored only partially (Figure 1D). The results show
that PToV-P4 HE0 is a high-specificity lectin for 9-mono-O-Ac-
Sia. Conversely, BCoV-Mebus and BCoV-LUN HE0 accept
9-mono-O-Ac-Sias but bind to 7,9-di-O-Ac-Sias with much
higher affinity (Figures 2A and 2B).
Although the BCoV and ECoV HEs would seem to favor 7,9-di-
O-Ac-Sias, their binding characteristics in sp-LBA indicate a dif-
ference in ligand preference. The ECoV-NC99 binding curve is
suggestive of high-affinity binding to select glycotopes that are
present in BSM in amounts considerably lower than those of
Figure 2. Nidovirus Virolectins Display Distinct O-Ac-Sia Specificity
(A) sp-LBA as in (Figure 1B) with native and mutant virolectins (HE0-Fc of PToV-P4, BCoV-Mebus, and BCoV-LUN and BCoV-LUN/L161A) and BSM preparations
of defined Sia content. Non-modified BSM (native); BSM, mono-specific for 9-mono-O-Ac-Sias (9-O-Ac-BSM), or 7,9-di-O-Ac-Sias (7,9-O-Ac-BSM); BSM,
depleted for all O-Ac-Sias (de-O-Ac-BSM). Relative binding (in percentages) was calculated with binding to native BSM set at 100%. BSM preparations were
calibrated by dilution in coating buffer such as to ensure that the amounts of remaining O-Ac-Sia species in 9-O-Ac- and 7,9-di-O-Ac-BSM preparations were
comparable to those in native BSM.
(B) GLC-EIMS profiles of corresponding BSMpreparations (peaks numbered as in Table S2: peak 2; b-Neu5Ac, peak 3; b-Neu5,7Ac2, peak 4; b-Neu5,9Ac2, peak
5; b-Neu5,7,9Ac3, peak 6; a-Neu5,9Ac2, peak 9; b-Neu5Gc7Ac, peak 11; b-Neu5Gc7,9Ac2, peak 12; b-Neu5Gc9Ac, peak 13; a-Neu5Gc9Ac).
(C) Surface representation of the receptor binding site of BCoV-Mebus HE in complex with a-Neu5,9Ac22Me (PDB: 3CL5); the patch, contributed by T
114, is
colored in orange.
(D) Difference in affinity between BCoV-Mebus and -LUN HE0 attributed to a single amino acid change in the Sia binding site. Virolectins were compared for
relative binding to BSM by sp-LBA as in (Figure 1B).
(E) Surface and stick representations of the BCoV-Mebus HE lectin site in complex with a-Neu5,7,9Ac32Me as modeled by molecular docking (Trott and Olson,
2010). L161 is highlighted. Note the proximity of the L161 side-chain to the Sia-7-O-Ac-methyl (3.8 A˚), favorable for van der Waals interaction, and the burying of
hydrophobic surface.
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BCoVHE (Figure 1B). Thus, ECoVHEmay preferentially bind to a
subpopulation of the BCoV HE ligands or bind a distinct 9-O-Ac-
Sia variant altogether. The combined results establish that the
ECoV-NC99, BCoV-Mebus/LUN and PToV-P4 virolectins each
have distinct ligand preferences and distinguish between closely
related 9-O-Ac-Sia populations.
Structural Evidence that BCoV HE Preferably Binds 7,9-
Di-O-Ac-Sias
The structure of BCoV-Mebus HE, complexed with a synthetic
9-O-Ac-Sia analog, was solved to 1.8 A˚ (Zeng et al., 2008).
BCoV-LUN HE differs from that of BCoV-Mebus in only seven
residues, one of which is in a loop at the rim of the Sia binding
site (Figure 2C). This single amino acid variation (T114 in BCoV-
Mebus, I114 in BCoV-LUN HE) fully accounts for the observed
3-fold difference in binding affinity toward BSM (Figures 1B
and 2D). Apparently, the Thr/Ile substitution does not alter lectin
ligand preference for 7,9-di-O- over 9-mono-O-Ac-Sias; as
compared to BCoV-Mebus HE, LUN HE displays equally
increased affinities for either Sia type (Figure 2A). Based on the
position of T114 relative to the bound ligand, its exchange by Ile
may affect, directly or indirectly, binding site interactions with
the Sia-5-N-acyl moiety. Although not immediately obvious
from replacement modeling how this would be achieved, such
interactions may raise binding affinity for Sia per se but, as indi-
cated by glycan array analysis (vide infra), also alter the lectin’s
relative preference for 5-N-Ac- or 5-N-Gc-Sias.
To determine the structural basis for BCoV HE’s ligand prefer-
ence for di-O-Ac-Sias over 9-mono-O-Ac-Sias, we examined
the lectin-Sia interface with particular focus on protein-sugar in-
teractions at the Sia glycerol side chain. The Sia 9-O-Ac group,
crucial to receptor binding, docks into a hydrophobic pocket.
The vicinity of Sia glycerol atom C8 is crowded such that substi-
tution of an O-Ac moiety for the C8 hydroxyl is not possible
without introducing steric strain. Hence, the structure of the
BCoV HE receptor binding site appears incompatible with
binding of 8-O-Ac-Sias. There is, however, ample space to
accommodate modifications at C7. Moreover, modeling of
Neu5,7,9Ac3 in the lectin binding site revealed potential interac-
tions between the Sia-7-O-Ac moiety and the side chains of F211
and L161 that could contribute to the lectin’s preference for
7,9-di-O-Ac-Sias (Figure 2E). Accordingly, L161A substitution
strongly decreased binding to BSM, yet, as demonstrated for
BCoV-LUN HE, high-affinity binding to 7,9-di-O-Ac-Sias was
affected more than low-affinity binding to 9-mono-O-Ac-Sias
(Figure 2A). In effect, ligand fine specificity was lost, the substi-
tution causing the BCoV-LUN HE L161A mutant to now bind
each receptor type equally poorly.
Glycan Microarray Analysis of Nidovirus Virolectins
Conceivably, HE ligand preference could be influenced by (1) the
presence or absence of other Sia modifications such as 5-N-gly-
colylation, (2) the type of glycosidic linkage, and/or (3) the overall
composition and structure of the underlying glycan (Deng et al.,
2013). We therefore systematically compared the binding prop-
erties of the HEs of BCoV-LUN, BCoV-Mebus, ECoV-NC99, and
PToV-P4 toward paired (Neu5Ac- or Neu5Gc-based, and a2-3
or a2-6-linked) 9-O-Ac and non-O-Ac-sialoglycans by glycanmi-
croarray analysis (Padler-Karavani et al., 2011; Padler-Karavani
et al., 2012). The results, summarized in Figures 3A and S3, indi-
cate that all four lectins accept both a2-3- and a2-6-linked 9-O-
Ac-Sias, though with noted exceptions apparently related to
overall glycan structure/composition. The most prominent and
consistent difference was in the relative binding preference for
Sias, differentially modified at C5. The PToV-P4 and ECoV-
NC99 lectins displayed a clear binding bias and strongly favored
5-N-Ac-Sias. Conversely, BCoV-LUN and Mebus HEs more
readily accepted both 5-N-Ac- and 5-N-Gc-Sias, albeit depend-
ing on the underlying glycan structure. Of the two lectins, BCoV-
LUN HE bound more strongly to all ligands, in accordance with
sp-LBA data (Figure 1B), and displayed a higher apparent affinity
for 5-N-Gc-Sias. The results provide a clue to the observed dif-
ference between BCoV and ECoV-NC99 HEs in sp-LBA (Fig-
ure 1B). BSM predominantly carries sialyl-Tn-type O-glycans
(Kozak et al., 2012), represented in the microarray by glycans
#23 and #24. In contrast to the BCoV HEs, ECoV-NC99 HE binds
9-O-Ac-5-N-Ac-sialyl Tn exclusively (glycan #23; Figure 3A) and
not to its 5-N-glycolylated variant (glycan #24) and hence would
recognize only a subpopulation of the BCoV HE glycotopes.
Although glycan array analysis provides insight into the bind-
ing properties of the lectins, caution is warranted, as the number
of glycans included in the array is limited and does not reflect the
full spectrum of natural O-Ac-sialoglycans. Sias with multiple
O-Ac moieties are absent, as are multi-antennary sialoglycans.
Furthermore, differences in binding as detected by glycan array
analysis may occur from differences in presentation and/or flex-
ibility of the printed glycans and from how such variables would
affect multivalent lectin-Sia interactions (Padler-Karavani et al.,
2012). Finally, the biophysical and biological consequences of
modest differences in binding preference as detected by glycan
array analysis are difficult to predict. Such differences may be
augmented and of major significance during multivalent HE-
mediated virion attachment in vivo. Conversely, viral attachment
to suboptimal ligandsmaywell occur, if such glycans are present
in high local densities. At any rate, the 9-O-Ac-sialoglycan pop-
ulations recognized by the PToV, BCoV, and ECoV virolectins
cannot be defined in absolute terms. Their binding profiles, while
unique, partially overlap. PToV-P4 would seem to be the most
specific in that it displays a strong predilection for 9-mono-O-
acetylated, 5-N-acetylated Sias, and BCoV-LUN HE the least
(for a summary of binding profiles, see Figure 3B).
Differential Expression of 4-O- and 9-O-Ac-Sias in
Cultured Mammalian Cells
Various reagents have been used to detect O-Ac-Sia species,
including lectins of the African landsnail Achatina fulica (Ghosh
et al., 2007; Mukherjee et al., 2008) and Californian crab Cancer
antennarius (Parameswaran et al., 2013), salmon infectious ane-
mia virus HE extracted from infected cells (Aamelfot et al., 2014),
and the heterologously expressed ectodomain of influenza C
HEF (Cariappa et al., 2009; Klein et al., 1994; Krishna and Varki,
1997; Shi et al., 1996, 1998; Sjoberg et al., 1994). The present
study extends previous work in that it builds on a comprehensive
set of viral lectins and SOAEs, extensively characterized both in
terms of structure and ligand/substrate fine specificity. In combi-
nation withMHV-SHE0, the virolectins of PToV-P4, ECoV-NC99,
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and BCoV-LUN should allow detection in situ of 4-O-Ac-Sias,
three distinct populations of 9-O-Ac-sialoglycans and combina-
tions thereof. For convenience and clarity, we refer to the virolec-
tins and their glycotopes according to virus strain designation
(MHV-S, P4, LUN, and NC99) in the remainder of the text.
Screening of mammalian continuous cell lines by lectin-immu-
nofluorescence assay (L-IFA) revealed that the Sia populations
as detectable by the four virolectins are expressed differentially
(Figures 4, 5, and S4). There are considerable differences in
expression of Sia subtypes among cell lines and, more remark-
ably, even among individual cells within the same clonal cell pop-
ulation. All cell lines expressed P4- and LUN-type 9-O-Ac-Sias
(Table S4), most often in an intracellular compartment reminis-
cent of the Golgi complex. Indeed, in HeLa cells, 9-O-Ac-Sias
co-localized with established Golgi markers (Figure S4A).
For a select number of human (HRT-18) and animal cell lines
(MDCK and MDBK), extensive surface expression of 9-O-Ac-
Siaswas observed, but, again, only in subpopulations of the cells
(1%–10%; Figure 4A). HRT-18 sublineages (n = 3) obtained
through single-cell cloning by limiting dilution were indistinguish-
able from the parental cell line, indicating that the observed Sia
Figure 3. Glycan Array Analysis
(A) Differential recognition of 9-O-Ac-sialoglycans
by theHEs of PToV-P4, BCoV-LUN, BCoV-Mebus,
and ECoV-NC99. The library of glycans tested (n =
40; listed in Figure S3) was designed to test the
influence on lectin binding of (1) glycosidic linkage
of 9-O-Ac-Sia (a2-3 versus a2-6) and (2) modifi-
cations at Sia atom C5 (N-acetylation, 5-N-Ac,
versus N-glycosylation, 5-N-Gc; bottom). Data
presented as mean ± SD.
(B) HE0-Fc virolectins. Summary of ligand prefer-
ence profiles based on present and published
observations (Zeng et al., 2008, Langereis et al.,
2009; Langereis et al., 2012). N.A., not analyzed.
See also Figure S3.
expression patterns did not result from
genetic heterogeneity (data not shown).
Synthesis of cell-surface P4- and LUN-
type 9-O-Ac-Sias in HRT-18 cells was
sensitive to benzyl N-acetyl-a-D-galacto-
saminide (benzyl-GalNAc) but resistant
to N-butyl-deoxynojirimycin (NB-DNJ),
N-butyl-deoxygalactonojirimycin (NB-
DGB), and N-butyl-deoxymannojirimycin
(NB-DMJ), suggesting that they are
attached mainly to O-linked glycans
rather than to N-linked sugars or glyco-
lipids (Figure 4B; Gouyer et al., 2001; Platt
et al., 1994). As a rule, P4 glycotopes
were most abundant and those of NC99
least. Most cells expressing NC99 glyco-
topes also expressed LUN-type Sias, and
in turn, most cells stained by LUN also
produced Sias detectable by P4 (Fig-
ure 4A). However, relative expression
levels of each 9-O-Ac-Sia subtype varied
widely from one cell to another, and cells that would seem to ex-
press LUN- or NC99-type Sias predominantly or even exclu-
sively were also readily detected (Figure 4A). These findings
demonstrate that P4, LUN, and NC99 can detect and distinguish
between distinct 9-O-Ac-Sia populations also in cultured cells.
In two other human cell lines, HeLa and HEK293T, expression
of 9-O-Ac-Sias appeared more uniform in that virtually all cells
produced P4-type Sias and a significant proportion of cells
LUN-type Sias as well. These Sias, however, were found exclu-
sively intracellularly (Figures 4C and S4B). Why HeLa and
HEK293T cells do not express detectable levels of 9-O-Ac-
Sias at the plasmamembrane is not known. Clearly, an apparent
failure of virolectins to bind to the cell surface as determined
by L-IFA does not necessarily mean absence of their cognate
ligands. Bearing the dynamics of lectin-ligand interactions in
mind, in particular the vast incremental effect of ligand valency
on apparent lectin affinity (Dam and Brewer, 2010; Dam et al.,
2007), the virolectins may predominantly bind to multivalent gly-
coconjugates with clustered binding sites. Thus, the lack of cell-
surface staining in HeLa and HEK293T cells might be explained
from a lack of expression of specific cell surface mucin-type
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glycoproteins that are selectively (and profusely) decorated with
O-Ac-Sias.
All human cell lines were tested negative by L-IFA for MHV-S-
type 4-O-Ac-Sias (Table S4). This virolectin did bind, however, to
cells of mouse and horse, i.e., animal species known to express
4-O-Ac-Sias (Aamelfot et al., 2014; Corfield et al., 1976; Rin-
ninger et al., 2006). Whereas in murine LR7 cells, 4-O-Ac-Sias
were detected exclusively intracellularly (data not shown), in
equine cell lines, both intracellular and cell-surface expression
were seen (Figures 5 and S4C). Approximately 1% of these cells
expressed 4-O-Ac-Sias on the surface, whereas in 3%–5%, this
Sia was detected only intracellularly (Figure 5A). L-IFA double
staining showed that Ederm cells also express LUN- and P4-
Figure 4. Differential Expression of O-Ac-
Sias in Cultured Human Cells as Detected
by L-IFA
(A) Surface expression of P4- (green) and LUN-
type (red) Sias in PFA-fixed, non-permeabilized
HRT-18 cells. Nuclei (N) stained with Hoechst-
33258 (blue). M, merged images.
(B) Sensitivity of cell-surface Sia-O-acetylation to
glycosylation inhibitors. Cells were stained for P4-
and LUN-type Sias after drug treatment (merged
images).
(C) Double L-IFA on HEK293T and HeLa cells
stained for P4- and LUN-type Sias (merged
images).
(D) HRT-18 cells, selected for O-Ac-Sia surface
expression or lack thereof, revert to Sia hetero-
geneity. HRT-18 populations, enriched or depleted
for cells expressing high levels of P4- or LUN-type
Sias by magnetic-activated cell sorting (MACS),
were cultured for 3, 5, or 7 days. Cell-surface
O-Ac-Sia expression was analyzed by flow
cytometry.
See also Figure S4 and Table S4.
type 9-O-Ac-Sias, albeit again at relative
levels that varied from one individual
cell to another (Figures 5A and 5B). In
contrast to 4-O-Ac-Sias, 9-O-Ac-Sias
were retained intracellularly.
Interestingly, upon treatment of equine
cells with Arthrobacter ureafaciens siali-
dase (AuS), most, yet not all, P4-type 9-
O-Ac-Sias were cleaved (Figure 5A).
AuS-resistant 9-O-Ac-Sias were present
invariably in cells that also produced
4-O-Ac-Sias. Given that 4-O-acetylation
protects Sias against cleavage by AuS
and other sialidases (Corfield et al.,
1986), we hypothesized that the AuS-
resistant Sias detected by P4 were both
9- and 4-O-acetylated. Accordingly, in
cells treated with AuS and sialate-4-O-
acetylesterase (MHV-S HE+), all 9-O-Ac-
Sias were removed (Figure 5A), providing
compelling evidence that equine cells
produce 4,9-di-O- in addition to 4-
mono-O-Ac-Sias. The results (1) show that nidovirus virolectins
can indeed be used to detect and distinguish between different
forms of 4-O- and 9-O-Ac-sialoglycans in individual cells and (2)
illustrate how novel types of multiply modified Sias can be
discovered and demonstrated in situ, by using viral andmicrobial
SOAEs and sialidases in combination with L-IFA.
Differential Expression of 4-O- and 9-O-Ac-Sias in
Human and Murine Tissues
Nidovirus HEs also allowed in situ detection of O-Ac-Sias in
mammalian tissues (Table 1; Figures S5 and S6). In accordance
with analytic chemical findings (Rinninger et al., 2006), 4-O-Ac-
Sias were readily detectable in multiple organs and cell types
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in mice (most abundantly in the colon; Table 1; Figure S5). All
human tissues, however, were negative (Table 1).
9-O-Ac-Sias occur in various tissues in both human and
mouse, albeit more profusely and widespread in the latter spe-
cies (Table 1; Figures S5 and S6). Among noted species differ-
ences in Sia expression, murine, but not human, erythrocytes
are covered with LUN and P4-type 9-O-Ac-Sias. However, in
various organs and cell types, humans and mice display similar
9-O-Ac-Sia profiles, with P4 and LUN glycotopes differentially
expressed in comparable fashion. For example, in the prostate,
epithelial cells lining the ducts display low-level expression of
P4- and high-level expression of LUN-type Sias (Figures S5
and S6). In both species, secreted colonic mucus contains
high levels of P4- and LUN-type Sias, but the mucin-producing
goblet cells predominantly stain with P4 (Figures S5 and S6).
Differential expression of P4 and LUN glycotopes wasmost con-
spicuous in the brain, particularly in the cerebellum (Figure 6, S5,
and S6). In human and mouse, individual Purkinje cells differed
widely in 9-O-Ac-Sia profile, with cells seemingly devoid of
9-O-Ac-Sias, adjacent to ones containing large quantities of
P4- and/or LUN-type 9-O-Ac-Sias in granular inclusions in
the cell body (Figure 6D). Even within single cells, P4- and
Figure 5. Differential Expression of O-Ac-Sias in Equine Cells
(A) Expression of 4-O- and 9-O-Ac-Sias in Ederm cells as detected by L-IFA
with MHV-S (green) and PToV-P4 (red) HE0-Fc, respectively. Nuclei were
stained with Hoechst-33258 (blue). Permeabilized cells were treated with
MHV-S HE+-Fc (HE), sialidase (AuS), or both (HE++AuS) or mock treated, prior
to L-IFA.
(B) Differential expression of P4- and LUN-type Sias in Ederm cells.
(C) Expression of P4- and LUN-type Sias in FHK cells.
See also Figure S4 and Table S4.
Table 1. Virolectin Staining Profiles of Human and Murine
Tissues
Human Tissue Array Mouse Tissue Array
MHV-S P4 LUN MHV-S P4 LUN
Adrenal gland  + + ND ND ND
Aorta    ND ND ND
Bladder     + +++
Breast    ND ND ND
Colon  +++ ++ ++++ +++ ++
Cerebellum  + ++  + +++
Endothelium    ? +++ 
Erythrocytes    ? +++ +++
Esophagus     + +
Eye ND ND ND  + ++
Gray matter  + ++  + +++
Heart     + +
Kidney     ++ ++
Liver     + +
Lymph node    ND ND ND
Lung     +++ +++
Ovary ND ND ND  + +
Pancreas  + +  ++ ++
Prostate  + ++ + + ++
Salivary gland  ++ ++  +++ +++
Skeletal muscle     + +
Skin    ++ + +
Small intestine   +  + +
Spleen    ++ ++ ++
Stomach    + ++ ++
Thymus    + + +
Testis ND ND ND   
Tonsil    ND ND ND
Thyroid    ND ND ND
Umbilical cord    ND ND ND
Uterus    + ++ ++
White matter    ND ND ND
ND, not determined. See also Figures S5 and S6.
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Figure 6. Differential Expression of P4 and LUN-
Type Sias in Human and Murine Cerebellum
(A) Immunohistochemical staining of cross-sections of
mouse brain with P4 (DAB) and LUN (VectorRed).
Images in pseudo-colors (hematoxylin [Htx], blue; P4
and LUN in red or green as indicated) were created by
spectral analysis.
(B) Blowup of (A).
(C) RBCs in blood vessels stain with P4 and LUN.
(D and E) Differential expression of O-Ac-Sias in human
Purkinje cells detected by conventional light micro-
scopy (D) or by double lectin staining and spectral
analysis (E) as in (A).
(F) Serial sections of mouse cerebellum stained
with virolectins after mock treatment (left), enzymatic
depletion of 9-O-Ac-Sia moieties (middle), or subse-
quent C7-to-C9 O-acetyl migration (right).
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LUN-type 9-O-Ac-Sias were often found in different compart-
ments (Figure 6E). Most strikingly, in the mouse, the dendritic
arbors of 9-O-Ac-Sia-producing Purkinje neurons stained for
LUN-type 9-O-Ac-Sias only, creating a striated, bar code-like
pattern in the molecular layer in the cerebellar cortex (Figures
6A–6C, 6F, and S5; note the robust staining of RBCs by P4).
This pattern was less conspicuous in the human cerebellum,
but also here, dendritic arbors stained with LUN and not with
P4 (Figure S6). NC99- and LUN-staining of Purkinje cells resulted
in identical patterns in serial sections of mouse cerebellum (Fig-
ure 6F), arguing against the lack of P4-binding resulting from
exclusive expression of 5-N-Gc-Sias (Figure 3). In fact, Neu5Gc
is exceedingly rare even in the murine brain (Davies and Varki,
2013) and completely absent in humans (Chou et al., 1998). To
test whether lack of P4 binding was due to prevalent Sia-7,9-
di-O-acetylation in Purkinje cells, sections of mouse cerebellum
were enzymatically depleted for 9-O-Ac-Sias while preserving
7-O-Ac-Sias. In consequence, staining of Purkinje cells and
RBCs by both P4 and LUN was lost. Subsequent pH/tempera-
ture-induced C7-to-C9 migration of the remaining Sia-7-O-Ac
moieties restored staining of RBCs by P4, but saliently, that by
LUN aswell. While these findings provide independent confirma-
tion that erythrocytes do express 7,9-di-O-Ac-Sias (presenting a
source for 9-mono-O-Ac-Sias upon experimentally induced C7-
to-9-O-Ac migration), they also show that in tissue sections, un-
der the conditions applied, LUN binds 9-mono-O-Ac-Sias too
(Figure 6F). Importantly, the conditions that restored Sia 9-O-
acetylation on RBCs did not generate P4 glycotopes in Purkinje
cell dendrites, nor salvaged LUN binding. It would thus appear
that the Sias in the mouse cerebellum are mainly 9-mono-O-
acetylated and that the differential staining of Purkinje cells by
P4 and LUN must be ascribed to a particular glycan structure
and/or to Sia modifications, additional to 9-O-acetylation, that
are tolerated by LUN, but not by P4. Although the LUN glyco-
topes in the cerebellum await definitive identification, our find-
ings do underscore the diversity and complexity of naturally
occurring O-Ac-sialoglycans and their cell(-type)-specific differ-
ential expression. It is fair to assume that like the virolectins used
here, cellular lectins distinguish between these Sia populations
and that regulation of lectin binding, through controlled Sia-O-
acetylation/de-O-acetylation, may have far-reaching biological
effects and consequences.
Viral Preference for O-Ac-Sialoglycan Receptor
Determinants and Host Tropism
Many viruses encode proteins that recognize, bind to, and
modify Sia-glycotopes with exquisite specificity (Matrosovich
et al., 2013; Neu et al., 2011; Stehle and Khan, 2014). Here, we
demonstrate that nidoviruses are even more fastidious with
respect to Sia receptor usage than appreciated so far. For all ni-
dovirus HEs studied, the ligand specificity and SOAE substrate
preference are in close accord (Figures 3B and S2C), indicative
of co-evolution of lectin and esterase domains. Apparently, Sia
subtype preference correlates with viral host tropism. The HE
proteins of PToV-Markelo and -P4 are highly divergent, with
only 77% identity in their ectodomains, yet both display a prefer-
ence for 9-mono-O-Ac-Sias. In contrast, the HEs of BCoV and
those of two distinct BToV lineages (represented by strains
Breda and B150), all preferentially bind to 7,9-di-O-acetylated li-
gands instead (Figure 3B). It would seem that in toroviruses and
lineage A betacoronaviruses, HE selectivity for O-Ac-Sia recep-
tor subtypes arose as an adaptation to the ‘‘sialomes’’ of the
target tissues in their respective hosts and that the shared pref-
erence of bovine corona- and toroviruses for 7,9-di-O-Ac-Sias
resulted from convergent evolution.
Cell-to-Cell Variability in O-Ac-Sialoglycan Synthesis:
Stochastic Gene Expression or Determinism?
Our results not only advance the understanding of virus-Sia in-
teractions and virus evolution but also, more importantly, show
how virolectins can be exploited as tools in sialoglycomics and
explorative glycobiology. One of our most striking observations
is the phenotypic heterogeneity among individual cells of ho-
mogenous clonal cell lines. Cells differed not only in the extent
to which they expressed O-Ac-Sias but also in the types of
O-Ac-Sias produced. Apparently, even in populations of tissue
culture cells, cell-to-cell variation occurs in the expression of en-
zymes required for the biosynthesis or degradation ofO-Ac-Sias
and/or of the glycoconjugates that are carry these sugars. This
cell-to-cell variability may be attributed to stochasticity (‘‘noisy’’
gene expression) but perhaps more likely arises from determin-
istic spatiotemporal influences such as population context and/
or cellular crowding (Snijder and Pelkmans, 2011). Indeed,O-Ac-
Sia-expressing cells tend to occur in islets (Figure 4A). HRT-18
subpopulations, selected by lectin-MACS for O-Ac-Sia surface
expression or lack thereof, reverted to Sia heterogeneity over
time (7 days) and a limited number of cell generations (Fig-
ure 4D), reminiscent of the short-term phenotypic memory
seen in other examples of cell-to-cell variability (Mariani et al.,
2010; Sigal et al., 2006). Our findings raise questions regarding
the triggers that induce or prevent Sia-O-acetylation in individual
cells but also offer ways and means to study this phenomenon
and the mechanisms involved. On a more technical note, our
observations illustrate the intricacies of (sialo)glycobiology and
underline the pitfalls and limitations of functional glycomics
approaches based upon averaging sialoglycan content of cell
populations and whole tissue samples.
O-Ac-Sialoglycan Expression in Mammals: Cell, Tissue,
and Species Specificity
Comparative analysis of mouse and human revealed important
differences in Sia repertoire and sialylation profiles. For
example, 4-O-Ac-Sias, abundant in mice (and horses), were
not detected by virolectin histochemistry in humans, either in
cultured cells or in tissues. Of two reports of 4-O-Ac Sias in hu-
mans, one involved a Sia variant, Neu4Ac5Gc (Miyoshi et al.,
1986), of established non-human, dietary origin (Banda et al.,
2012; Tangvoranuntakul et al., 2003). The other observation of
Neu4,5Ac2 and 9-O-lactylated Neu4,5Ac2 in human erythro-
cytes (Bulai et al., 2003) as yet awaits independent confirmation.
We cannot exclude that 4-O-Ac-Sias are expressed infre-
quently, in concentrations below our detection levels, and/or
specifically in distinct types of tissues and cells absent from
our human tissue arrays. Yet, the data lead us to consider
that humans might not produce this type of Sia after all.
Such a deficiency would not be without precedent: defective
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synthesis of Neu5Gc sets us apart even from our closest non-
human relatives (Chou et al., 2002).
9-O-Ac-sialoglycans occur in both human and mouse and
apparently are expressed in a well-coordinated cell- and tis-
sue-specific fashion. There are species differences in tissue dis-
tribution of distinct 9-O-Ac-Sias, and, in general, these sugars
are more widely and abundantly present in the mouse. More
importantly, however, in several key organs and tissues, partic-
ularly in the brain, mice and humans share highly similar 9-O-
Ac-Sia expression profiles, suggestive of evolutionary and func-
tional conservation.
Conclusions and Perspectives
The present work opens avenues for the exploration of the vast
and uncharted territory that is sialoglycobiology. The challenge
ahead will be to answer the many questions raised by present
observations. For example, how is O-acetylation of Sias regu-
lated at the level of individual cells?What are the cues to activate
or inactivate the cellular SOATs and SOAEs to establish, main-
tain, and alter a particular cell (surface) sialylation profile? Which
enzymes and signaling pathways are involved?Which glycocon-
jugates are decorated with O-Ac-Sias? How does Sia-O-acety-
lation and the regulation thereof relate to cell function? Are there,
for example, functional differences between Purkinje cell popu-
lations that express O-Ac-Sias and those that do not, and why
is there a preference for expression of LUN- rather than P4-
type Sias in these neurons? The resources and methodology
described herewill help to settle these outstanding issues.More-
over, our understanding of themolecular basis of ligand and sub-
strate recognition by nidovirus HEsmay allow the construction of
designer lectins and enzymes of even higher affinity and more
narrow specificity to further facilitate such studies.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Nidovirus HE ectodomains and influenza virus C HEF-1 were transiently ex-
pressed in HEK293T cells as fusion proteins with aC-terminal Fc domain of hu-
man IgG1 or that of mouse or bovine IgG2a as described previously (Zeng
et al., 2008). HE-Fc proteins, purified from cell supernatants by protein A-affin-
ity chromatography, were eluted with 0.1 M citric acid (pH 3.0). Eluates were
neutralized with 1M Tris buffer (pH 8.8) (0.2M final concentration) and dialyzed
for 16 hr at 4C against PBS.
Hemagglutination Assay
Hemagglutination assays were performed with rat RBCs (Rattus norvegicus
strain Wistar; 50% suspension in PBS) and 2-fold serial dilutions of HE0-Fc
proteins (starting at 0.1 mg/ml) as described previously (Zeng et al., 2008).
For specific depletion of cell-surface O-Ac-Sias, RBCs were (mock) treated
with BCoV-Mebus, MHV-S, PToV-Markelo, or BToV-Breda HE+-Fc (0.2 mg/
ml) for 2 hr at 37C, washed with PBS, and resuspended to 50%. Animal use
was in accordance with legislation of the Netherlands and the European Union
and approved by the ethics committee for animal experiments of Utrecht
University.
Solid-Phase Lectin Binding Assay
Maxisorp 96-well plates (Nunc) were coated for 16 hr at 4C with native BSM
(10 mg/ml in PBS [pH 6.5]; 100 ml/well) or with BSM preparations, depleted for
specific O-Ac-Sias. For the production of BSM preparations with defined
O-Ac-Sia content, see the Supplemental Experimental Procedures. Two-fold
serial dilutions of HE0-Fc lectins in blocking buffer (PBS, 0.05% Tween-20,
2% BSA) were applied (starting at 0.1 mg/ml, 100 ml/well) for 1 hr at 37C. Incu-
bation was then continued with horseradish peroxidase (HRP)-conjugated
goat-a-human immunoglobulin (IgG) antibody (Southern Biotech; 1:1,000 in
blocking buffer) for 30 min at 37C. Washing was with PBS, 0.05% Tween-
20. Bound HE0-Fc was detected with TMB Super Slow One Component
HRP Microwell Substrate (BioFX). Optical densities (ODs) were measured at
450 nm.
For on-the-plate depletion of O-Ac-Sia receptors, native BSM coated on
Maxisorp plates was (mock) treated with 2-fold serial dilutions of BCoV-Me-
bus, PToV-P4 (starting at 0.1 ng/ml), or BToV-Breda (starting at 5 ng/ml) HE+ en-
zymes in PBS (pH 6.5) for 2 hr at 37C (100 ml/well). sp-LBA with BCoV-Mebus
(5 ng/ml) and PToV-P4 (1 ng/ml) lectins were as described. Depletion of O-Ac-
Sia receptors was calculated from the inverse of lectin bindingmeasurements,
expressed in percentages.
Lectin-Immunofluorescence Assay of Cultured Cells
Cell monolayers on glass coverslips were fixedwith PFA (3.7% in PBS, 15min),
either left non-permeabilized or permeabilized with PBS, 0.1% Triton X-100
(10 min), successively incubated (1 hr each) with blocking buffer (PBS,
0.05% Tween-20, 2% BSA) and with HE0-Fc lectins (MHV-S, 50 mg/ml;
PToV-P4, 20 mg/ml; ECoV-NC99, 100 mg/ml; BCoV-LUN, 100 mg/ml; concen-
trations used were 2- to 4-fold above saturation as determined by LBA
with 2-fold serial dilutions of each lectin), and then for 30 min with goat-
a-human IgG-Dylight488 and/or goat-a-bovine IgG-Dylight549 (Jackson
ImmunoResearch; 1:100), and with Hoechst-33258 (1:200). All incubations
were in blocking buffer. Washing was performed with PBS, 0.05% Tween-
20. The cells, embedded in FluorSave (Calbiochem), were examined by stan-
dard fluorescence microscopy (Leica DMRE).
Inhibitors were added to culture supernatants of HRT-18 cells (Benzyl-Gal-
NAc, 2.5 mM; NB-DNJ, 0.2 mM; NB-DGB, 0.1 mM; NB-DMJ, 0.1 mM). Incuba-
tion was continued for 72 hr. Cells were fixed and stained with PToV-P4 and
BCoV-LUN HE0-Fc lectins as described above. To de-O-acetylate or remove
cell-surface Sias prior to L-IFA, PFA-fixed Ederm cells were incubated for 2 hr
at 37C with PBS, containing 20 mg/ml MHV-S HE+-Fc or 100 mU/ml Arthro-
bacter ureafaciens sialidase (AuS; Sigma-Aldrich), respectively.
Lectin Staining of Mammalian Tissues
Paraffin-embedded tissue sections (Gentaur; mouse tissue array, AMS541;
mouse brain, T2334035; human tissue array, AC1; human cerebellum,
T2234039) were dewaxed in xylene and rehydrated. Endogenous peroxidases
were inactivated with peroxide (0.3% in methanol). For indirect chromogenic
detection of O-Ac-Sias, tissue sections were successively incubated with
HE0-Fc virolectins (20 or 40 mg/ml; optimal concentrations determined as
described for L-IFA), with biotinylated goat-a-human IgG or goat-a-mouse
IgG antibodies (Sigma-Aldrich; 1:250; lectins and antibodies all diluted in
blocking buffer), with avidin-biotin HRPO complex (ABC-PO staining kit,
Thermo Scientific), and with 3,30-diaminobenzidine (DAB; Sigma-Aldrich).
Blocking, incubations, and washing was as for L-IFA. Tissue sections were
counterstained with Mayer’s hematoxylin, embedded in Eukitt mounting
medium (Fluka) and examined by standard light microscopy. Simultaneous
detection of P4- and LUN-type Sias in human cells was performed with
PToV-P4 (20 mg/ml) and BCoV-LUN (40 mg/ml) HE0 fused to mouse and bovine
Fc-domains, respectively, and with a combination of HRP-conjugated goat-
a-mouse IgG- and alkaline phosphatase (AP)-conjugated goat-a-bovine IgG
antibodies (Jackson ImmunoResearch). Tissue sections were stained for AP
with the VectorRed AP Substrate kit (Vector) and for HRPO with DAB, and
further processed as above. Mouse tissues were treated likewise, but with
HE0s fused to human or bovine IgG Fc-domains. Spectral analysis (460 to
660 nm at 10-nm intervals) was performed as described (van der Loos,
2008) using a Leica BM5000 microscope (Leica Microsystems) with a Nuance
VIS-FL Multispectral Imaging System (Cambridge Research Instrumentation).
Images were analyzed with Nuance 2.4.
Glycan Sialoglycan Microarray
Glycan microarrays were prepared with epoxide-derivatized slides and pro-
cessed, essentially as described (Padler-Karavani et al., 2012). For detailed
procedures, see the Supplemental Experimental Procedures.
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Molecular Docking
The structure of a-Neu5,7,9Ac32Me was drawn using Chemsketch (Advanced
Chemistry Development). Docking simulations between BCoV-Mebus HE
(PDB: 3CL5) and a-Neu5,7,9Ac32Me were performed using AutoDock Vina
software (Scripps Research Institute) at a box size of 20 3 15 3 15 A˚, with
HE set as a rigid unit and with the ligand allowed to be flexible and adaptable.
Docking of a-Neu5,9Ac22Me predicted a Sia topology identical to that seen in
the crystal structure of the HE/a-Neu4,5,9Ac32Me complex thus validating the
simulation conditions (data not shown).
SUPPLEMENTAL INFORMATION
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